Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 rats
- 1 January 1994
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 31 (1), 11-25
- https://doi.org/10.1007/bf00689673
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Long term effects of tamoxifen: Biological Effects of Tamoxifen Working PartyEuropean Journal Of Cancer, 1993
- Tamoxifen induces hepatocellular carcinoma in rat liver: A 1-year study with two antiestrogensArchives of Toxicology, 1993
- An initiation-promotion assay in rat liver as a potential complement to the 2-year carcinogenesis bioassayFundamental and Applied Toxicology, 1991
- Tamoxifen for breast cancer: Associated endometrial cancerCancer, 1990
- Enhancement in rats by the liver tumor promoter ethinyl estradiol of a serum factor(s) which is stimulatory for hepatocyte DNA synthesisBiochemical and Biophysical Research Communications, 1989
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- A semipurified diet that suppresses phenobarbital promotion of hepatocarcinogenesis in the ratNutrition and Cancer, 1989
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- Non-genomic effects of estrogens and antiestrogensJournal of Steroid Biochemistry, 1988
- A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474British Journal of Cancer, 1971